Have a great idea for a money-making bioinformatics product? Think again, cautioned a panel of industry players at the BioITWorld conference in San Diego earlier this month.
“How do you write a business case when the competition is free?” Rudolph Potenzone, CEO of Lion Bioscience, Inc., asked rhetorically. “A pure bioinformatics play is tough. The need is satisfied by the public domain or a free database.”